Literature DB >> 19264914

MiRNAs and cancer.

Rosa Visone1, Carlo M Croce.   

Abstract

Cancer is the result of a complex multistep process that involves the accumulation of sequential alterations of several genes, including those encoding microRNAs (miRNAs). miRNAs are a class of 17- to 27-nucleotide single-stranded RNA molecules that regulate gene expression posttranscriptionally. A large body of evidence implicates aberrant miRNA expression patterns in most, if not all, human malignancies. This article reviews our current knowledge about miRNAs, focusing on their involvement in cancer and their potential as diagnostic, prognostic, and therapeutic tools.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19264914      PMCID： PMC2671346          DOI： 10.2353/ajpath.2009.080794

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


  57 in total

1.  Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a.

Authors:  Natalie Motsch; Thorsten Pfuhl; Jan Mrazek; Stephanie Barth; Friedrich A Grässer
Journal:  RNA Biol       Date:  2007-11       Impact factor: 4.652

Review 2.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

Authors:  Witold Filipowicz; Suvendra N Bhattacharyya; Nahum Sonenberg
Journal:  Nat Rev Genet       Date:  2008-02       Impact factor: 53.242

Review 3.  Getting to the root of miRNA-mediated gene silencing.

Authors:  Ana Eulalio; Eric Huntzinger; Elisa Izaurralde
Journal:  Cell       Date:  2008-01-11       Impact factor: 41.582

4.  Target protectors reveal dampening and balancing of Nodal agonist and antagonist by miR-430.

Authors:  Wen-Yee Choi; Antonio J Giraldez; Alexander F Schier
Journal:  Science       Date:  2007-08-30       Impact factor: 47.728

5.  MicroRNA signatures in human ovarian cancer.

Authors:  Marilena V Iorio; Rosa Visone; Gianpiero Di Leva; Valentina Donati; Fabio Petrocca; Patrizia Casalini; Cristian Taccioli; Stefano Volinia; Chang-Gong Liu; Hansjuerg Alder; George A Calin; Sylvie Ménard; Carlo M Croce
Journal:  Cancer Res       Date:  2007-09-15       Impact factor: 12.701

6.  MicroRNA-21 targets tumor suppressor genes in invasion and metastasis.

Authors:  Shuomin Zhu; Hailong Wu; Fangting Wu; Daotai Nie; Shijie Sheng; Yin-Yuan Mo
Journal:  Cell Res       Date:  2008-03       Impact factor: 25.617

7.  MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.

Authors:  Aaron J Schetter; Suet Yi Leung; Jane J Sohn; Krista A Zanetti; Elise D Bowman; Nozomu Yanaihara; Siu Tsan Yuen; Tsun Leung Chan; Dora L W Kwong; Gordon K H Au; Chang-Gong Liu; George A Calin; Carlo M Croce; Curtis C Harris
Journal:  JAMA       Date:  2008-01-30       Impact factor: 56.272

8.  MicroRNAs accurately identify cancer tissue origin.

Authors:  Nitzan Rosenfeld; Ranit Aharonov; Eti Meiri; Shai Rosenwald; Yael Spector; Merav Zepeniuk; Hila Benjamin; Norberto Shabes; Sarit Tabak; Asaf Levy; Danit Lebanony; Yaron Goren; Erez Silberschein; Nurit Targan; Alex Ben-Ari; Shlomit Gilad; Netta Sion-Vardy; Ana Tobar; Meora Feinmesser; Oleg Kharenko; Ofer Nativ; Dvora Nass; Marina Perelman; Ady Yosepovich; Bruria Shalmon; Sylvie Polak-Charcon; Eddie Fridman; Amir Avniel; Isaac Bentwich; Zvi Bentwich; Dalia Cohen; Ayelet Chajut; Iris Barshack
Journal:  Nat Biotechnol       Date:  2008-03-23       Impact factor: 54.908

9.  E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer.

Authors:  Fabio Petrocca; Rosa Visone; Mariadele Rapazzotti Onelli; Manisha H Shah; Milena S Nicoloso; Ivana de Martino; Dimitrios Iliopoulos; Emanuela Pilozzi; Chang-Gong Liu; Massimo Negrini; Luigi Cavazzini; Stefano Volinia; Hansjuerg Alder; Luigi P Ruco; Gustavo Baldassarre; Carlo M Croce; Andrea Vecchione
Journal:  Cancer Cell       Date:  2008-03       Impact factor: 31.743

10.  Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters.

Authors:  Andrea Ventura; Amanda G Young; Monte M Winslow; Laura Lintault; Alex Meissner; Stefan J Erkeland; Jamie Newman; Roderick T Bronson; Denise Crowley; James R Stone; Rudolf Jaenisch; Phillip A Sharp; Tyler Jacks
Journal:  Cell       Date:  2008-03-07       Impact factor: 41.582
View more
  185 in total

1.  Alteration in miRNA gene expression pattern in acute promyelocytic leukemia cell induced by arsenic trioxide: a possible mechanism to explain arsenic multi-target action.

Authors:  Seyed H Ghaffari; Davood Bashash; Majid Zaki Dizaji; Ardeshir Ghavamzadeh; Kamran Alimoghaddam
Journal:  Tumour Biol       Date:  2011-11-10

2.  Adrenal cortex and micro-RNAs: An update.

Authors:  Fabio Rueda Faucz; Constantine A Stratakis
Journal:  Cell Cycle       Date:  2010-10-13       Impact factor: 4.534

3.  Genetic variation in miR-100 rs1834306 is associated with decreased risk for esophageal squamous cell carcinoma in Kazakh patients in northwest China.

Authors:  Jianbo Zhu; Lan Yang; Weiyan You; Xiaobin Cui; Yunzhao Chen; Jianming Hu; Wei Liu; Shugang Li; Xiaoyue Song; Yutao Wei; Wenjie Zhang; Feng Li
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

Review 4.  Cancer models in Caenorhabditis elegans.

Authors:  Natalia V Kirienko; Kumaran Mani; David S Fay
Journal:  Dev Dyn       Date:  2010-05       Impact factor: 3.780

5.  MiR-146b-5p suppresses EGFR expression and reduces in vitro migration and invasion of glioma.

Authors:  Mark Katakowski; Xuguang Zheng; Feng Jiang; Thomas Rogers; Alexandra Szalad; Michael Chopp
Journal:  Cancer Invest       Date:  2010-09-27       Impact factor: 2.176

Review 6.  Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma: a review of the current understanding of epidemiology, biology, risk stratification, and management of myeloma precursor disease.

Authors:  Amit Agarwal; Irene M Ghobrial
Journal:  Clin Cancer Res       Date:  2012-12-05       Impact factor: 12.531

7.  The transcriptional consequences of somatic amplifications, deletions, and rearrangements in a human lung squamous cell carcinoma.

Authors:  Lucy F Stead; Stefano Berri; Henry M Wood; Philip Egan; Caroline Conway; Catherine Daly; Kostas Papagiannopoulos; Pamela Rabbitts
Journal:  Neoplasia       Date:  2012-11       Impact factor: 5.715

Review 8.  MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Takatsugu Kan; Stephen J Meltzer
Journal:  Curr Opin Pharmacol       Date:  2009-09-19       Impact factor: 5.547

9.  Controlling the specificity of modularly assembled small molecules for RNA via ligand module spacing: targeting the RNAs that cause myotonic muscular dystrophy.

Authors:  Melissa M Lee; Jessica L Childs-Disney; Alexei Pushechnikov; Jonathan M French; Krzysztof Sobczak; Charles A Thornton; Matthew D Disney
Journal:  J Am Chem Soc       Date:  2009-12-02       Impact factor: 15.419

10.  The role of flexibility in the rational design of modularly assembled ligands targeting the RNAs that cause the myotonic dystrophies.

Authors:  Matthew D Disney; Melissa M Lee; Alexei Pushechnikov; Jessica L Childs-Disney
Journal:  Chembiochem       Date:  2010-02-15       Impact factor: 3.164
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.